Raia Drogasil SA (RADLY)
Raia Drogasil Market Cap: 8.384B for Jan. 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Hypera SA | 2.753B |
| CEL-SCI Corp. | 16.30M |
| AIM ImmunoTech, Inc. | 3.456M |
| IGC Pharma, Inc. | 26.02M |
| NovaBay Pharmaceuticals, Inc. | 825.37M |
Market Cap Related Metrics
| PE Ratio | 35.00 |
| PS Ratio | 1.097 |
| PEG Ratio | 4.708 |
| Price to Book Value | 6.383 |
| Price to Free Cash Flow | 26.62 |
| Price | 4.704 |
| Earnings Yield | 2.86% |
| PEGY Ratio | 3.808 |
| Operating PE Ratio | 18.18 |
| Normalized PE Ratio | 34.36 |